Vanguard Fiduciary Trust
CLB icon

Vanguard Fiduciary Trust’s Core Laboratories CLB Stock Holding History

Vanguard Fiduciary Trust’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.46M Buy
296,584
+7,022
+2% +$100K ﹤0.01% 2397
2026
Q1 		$4.86M Buy
+289,562
New +$5.18M ﹤0.01% 2092

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Fiduciary Trust's CLB Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Core Laboratories (CLB) stake by 2.4% in Q2 2026, buying an estimated $100K and bringing the position to 296,584 shares worth $3.46M. The position accounts for ﹤0.01% of the portfolio, ranked #2397.

Vanguard Fiduciary Trust first reported a position in CLB in Q1 2026 and has held it in 2 quarters since. The position peaked at $4.86M in Q1 2026. 185 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Vanguard Fiduciary Trust held 296,584 shares of Core Laboratories worth $3.46M as of Q2 2026.
  • Vanguard Fiduciary Trust bought 7,022 Core Laboratories shares in Q2 2026, an estimated $100K.
  • Core Laboratories made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #2397 holding.
  • Vanguard Fiduciary Trust first reported a position in Core Laboratories in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's Core Laboratories position peaked at $4.86M in Q1 2026.
  • 185 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.